NMTR

9 Meters Biopharma, Inc. Common Stock
NMTR

Overview Fund Activity
Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

26 hedge funds and large institutions have $16.3M invested in 9 Meters Biopharma, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
6
Reduced
4
Closed
8
Calls
$62K
Puts
–
Net Calls
+$62K
Net Calls Change
+$14K

Top Buyers

1
O
OrbiMed
New York
$14.6M
2
GPCM
Granite Point Capital Management
Massachusetts
$623K
3
TRCT
Tower Research Capital (TRC)
New York
$108K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
$58K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
$30K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
$74K
2
BlackRock
BlackRock
New York
$156K
3
Citadel Advisors
Citadel Advisors
Florida
$0
4
HWA
Heritage Wealth Advisors
Virginia
$11.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
$410K
Name Holding Trade Value Shares
Change 		Shares
Change %
Group One Trading
26
Group One Trading
Illinois
– -$2K -243 Closed
Deutsche Bank
27
Deutsche Bank
Germany
– -$2K -159 Closed
Bank of America
28
Bank of America
North Carolina
– -$1K -140 Closed
UBS Group
29
UBS Group
Switzerland
– -$1K -85 Closed
Morgan Stanley
30
Morgan Stanley
New York
– -$1K -50 Closed
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
– -$55 -6 Closed
1
2